Search publications

Publications

  • Fuente-Tomas L, Arranz B, Safont G, Sierra P, Sanchez-Autet M, Garcia-Blanco A and Garcia-Portilla MP.

    Classification of patients with bipolar disorder using k-means clustering.

    PLoS One . 14(1): . Number of citations: 16

    [doi:10.1371/journal.pone.0210314]

  • De la Fuente-Tomás L, Sierra P, Sanchez-Autet M, García-Blanco A, Safont G, Arranz B and García-Portilla MP.

    Sleep disturbances, functioning, and quality of life in euthymic patients with bipolar disorder.

    PSYCHIATRY RESEARCH . 269: 501-507. Number of citations: 11

    [doi:10.1016/j.psychres.2018.08.104]

  • Sánchez Autet M, Garriga M, Zamora FJ, González I, Usall J, Tolosa L, Benítez C, Puertas R and Arranz B.

    Screening of alcohol use disorders in psychiatric outpatients: influence of gender, age, and psychiatric diagnosis.

    Adicciones . 30(4): 251-263. Number of citations: 4

    [doi:10.20882/adicciones.885]

  • Costa J, García-Blanco A, Cañada Y, García-Portilla MP, Safont G, Arranz B, Sanchez-Autet M, Livianos L, Fornés-Ferrer V and Sierra P.

    Are affective temperaments determinants of quality of life in euthymic patients with bipolar disorder?

    JOURNAL OF AFFECTIVE DISORDERS . 230: 101-107. Number of citations: 4

    [doi:10.1016/j.jad.2018.01.007]

  • Sanchez-Autet M, Arranz B, Safont G, Sierra P, Garcia-Blanco A, de la Fuente L, Garriga M and García-Portilla MP.

    Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.

    JOURNAL OF AFFECTIVE DISORDERS . 229: 95-104. Number of citations: 13

    [doi:10.1016/j.jad.2017.12.038]

  • Arranz B, Garriga M, García-Rizo C and San L.

    Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 28(2): 227-242. Number of citations: 11

    [doi:10.1016/j.euroneuro.2017.12.006]

  • Butjosa Molines A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.

    Development and validation of the Questionnaire of Stressful Life Events (QSLE).

    JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Number of citations: 3

    [doi:10.1016/j.jpsychires.2017.08.016]

  • Garriga M, Solé E, González-Pinto A, Selva-Vera G, Arranz B, Amann BL, Saiz-Ruiz J, Pérez-Blanco J and Vieta E.

    Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial.

    EUROPEAN NEUROPSYCHOPHARMACOLOGY . 27(10): 959-969. Number of citations: 9

    [doi:10.1016/j.euroneuro.2017.08.429]

  • Rubio-Abadal E, del Cacho N, Saenz-Navarrete G, Arranz B, Cambra RM, Cuadras-Palleja D, Rodante D, Fehér C, Roca M, Barneda V, Usall J and PROLACT Group.

    How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment

    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY . 36(5): 422-428. Number of citations: 17

    [doi:10.1097/JCP.0000000000000539]

  • San L and Arranz B.

    Nalmefene: A new approach in the management of alcohol dependence disorders?

    Psiquiatría Biológica . 23(1): 29-35.

    [doi:10.1016/j.psiq.2016.02.006]